About Fesca
Our goals
The purpose
Board of FESCA
Our mission
Our vision
Our position
Constitution
Website disclaimer
News
Newsletter
Members
Projects
BURQOL-RD
DESSCIPHER
DeSSCipher downloads
EUSHNet
IMPRESS
SPIN
WSF
Events
Categories
Locations
My Bookings
World Scleroderma Day
Unveiling Scleroderma
World Scleroderma Day 2016
World Scleroderma Day 2017 – SCLERODERMA WILL NOT TAKE MY SMILE
Systemic Sclerosis World Congress
1st Systemic Sclerosis World Congress
2nd Systemic Sclerosis World Congress
3rd Systemic Sclerosis World Congress
4th Systemic Sclerosis World Congress
5th Systemic Sclerosis World Congress
Scleroderma
Tips on Self Management
Links
Contact
Recent news |
FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease
Phase 2 clinical study for patients with diffuse cutaneous systemic sclerosis (dcSSc) or patients with pulmonary arterial hypertension (PAH)
SCLERODERMA WILL NOT TAKE MY SMILE – World Scleroderma Day 2017
Scleroderma app – now available for download
Press Release – Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease
DESSCIPHER
August 21, 2013
No comments
« Previous image
5th Systemic Sclerosis World Congress, Bordeaux. February 15-17 2018
World Scleroderma Day 2017
DESSCIPHER
The first international EU-funded research project to decipher the optimal management on Systemic Sclerosis
Upcoming events
<<
Feb 2018
>>
M
T
W
T
F
S
S
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
1
2
3
4
Events
No events
World Scleroderma Foundation
Read our latest newsletter
We use cookies to ensure that we give you the best experience on our website. By using this site, you agree we can set and use cookies.
Ok